Sutro Biopharma Inc.

STRO | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.35

+$1.01 (+6.58%)

At close: Sep 21, 2026, 4:00 PM ET

$16.35

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+6.58%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $158.22M

1D Range

15.58 16.54

52W Range

7.15 43.85

Valuation (TTM)

PE -0.94

PB -1.53

EV/EBITDA -0.03

Valuation (NTM)

Forward PE N/A

Forward PEG 0.05

Price Target $51

Cash Flow

FCF Yield -92.0%

SBC Adj. FCF Yield -96.3%

SBC Impact -4.7%

Margins

Gross Margin 97.2%

Operating Margin -309.9%

FCF Margin -318.6%

Growth (CAGR)

Revenue 3Y | 5Y -7.0% | -7.9%

Dil EPS 3Y | 5Y 2.4% | 9.8%

FCF 3Y | 5Y -21.4% | -23.5%

Returns

ROA -92.9%

ROE 185.3%

ROIC -95.5%

Financial Health

Net Cash

$164.35M

Current Ratio 3.32

Interest Coverage -3.53

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-...

Sector Healthcare

Industry Biotechnology

Employees 128

IPO Date Sep 26, 2018

Website www.sutrobio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$50

Upside

+205.81%

Buy (6)

Hold (0)

Sell (0)

Analyst Details ➞